Does ECULIZUMAB Cause Upper respiratory tract infection? 269 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 269 reports of Upper respiratory tract infection have been filed in association with ECULIZUMAB (SOLIRIS). This represents 0.6% of all adverse event reports for ECULIZUMAB.
269
Reports of Upper respiratory tract infection with ECULIZUMAB
0.6%
of all ECULIZUMAB reports
7
Deaths
79
Hospitalizations
How Dangerous Is Upper respiratory tract infection From ECULIZUMAB?
Of the 269 reports, 7 (2.6%) resulted in death, 79 (29.4%) required hospitalization, and 4 (1.5%) were considered life-threatening.
Is Upper respiratory tract infection Listed in the Official Label?
Yes, Upper respiratory tract infection is listed as a known adverse reaction in the official FDA drug label for ECULIZUMAB.
What Other Side Effects Does ECULIZUMAB Cause?
Fatigue (4,858)
Off label use (4,228)
Haemoglobin decreased (3,028)
Headache (2,699)
Death (2,221)
Pyrexia (1,948)
Dyspnoea (1,819)
Asthenia (1,732)
Drug ineffective (1,644)
Nausea (1,579)
What Other Drugs Cause Upper respiratory tract infection?
ADALIMUMAB (3,306)
ETANERCEPT (2,948)
TOFACITINIB (1,805)
RITUXIMAB (1,713)
ABATACEPT (1,623)
METHOTREXATE (1,576)
TOCILIZUMAB (1,455)
APREMILAST (1,437)
PREDNISONE (1,354)
SECUKINUMAB (1,339)
Which ECULIZUMAB Alternatives Have Lower Upper respiratory tract infection Risk?
ECULIZUMAB vs EDARAVONE
ECULIZUMAB vs EDETATE
ECULIZUMAB vs EDOXABAN
ECULIZUMAB vs EDOXABAN TOSILATE
ECULIZUMAB vs EFALIZUMAB